Higher-risk APS: do we dare to DOAC?

Blood. 2018 Sep 27;132(13):1357-1358. doi: 10.1182/blood-2018-08-867036.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Antiphospholipid Syndrome*
  • Humans
  • Rivaroxaban
  • Stroke*
  • Warfarin

Substances

  • Anticoagulants
  • Warfarin
  • Rivaroxaban